A detailed history of Lpl Financial LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Lpl Financial LLC holds 211,419 shares of TEVA stock, worth $3.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
211,419
Previous 214,286 1.34%
Holding current value
$3.61 Million
Previous $3.48 Million 9.39%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$15.81 - $18.96 $45,327 - $54,358
-2,867 Reduced 1.34%
211,419 $3.81 Million
Q2 2024

Aug 07, 2024

SELL
$12.78 - $17.4 $597,413 - $813,380
-46,746 Reduced 17.91%
214,286 $3.48 Million
Q1 2024

May 10, 2024

BUY
$10.67 - $14.43 $419,106 - $566,795
39,279 Added 17.71%
261,032 $3.68 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $105,267 - $137,807
12,964 Added 6.21%
221,753 $2.32 Million
Q3 2023

Nov 13, 2023

SELL
$7.48 - $10.7 $155,539 - $222,495
-20,794 Reduced 9.06%
208,789 $2.13 Million
Q2 2023

Jul 31, 2023

SELL
$7.2 - $9.47 $257,076 - $338,126
-35,705 Reduced 13.46%
229,583 $1.73 Million
Q1 2023

May 10, 2023

SELL
$8.36 - $11.37 $31,065 - $42,250
-3,716 Reduced 1.38%
265,288 $2.35 Million
Q4 2022

Feb 07, 2023

SELL
$7.95 - $9.48 $69,681 - $83,092
-8,765 Reduced 3.16%
269,004 $2.45 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $129,729 - $225,986
18,911 Added 7.31%
277,769 $2.24 Million
Q2 2022

Aug 12, 2022

SELL
$7.38 - $10.4 $51,888 - $73,122
-7,031 Reduced 2.64%
258,858 $1.95 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $50,591 - $64,809
-6,902 Reduced 2.53%
265,889 $2.5 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $257,073 - $331,592
-32,541 Reduced 10.66%
272,791 $2.19 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $114,680 - $139,313
-13,685 Reduced 4.29%
305,332 $2.97 Million
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $56,628 - $66,123
5,720 Added 1.83%
319,017 $3.16 Million
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $33,966 - $42,080
3,285 Added 1.06%
313,297 $3.62 Million
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $201,930 - $258,921
23,453 Added 8.18%
310,012 $2.99 Million
Q3 2020

Nov 09, 2020

SELL
$8.57 - $12.69 $312,967 - $463,426
-36,519 Reduced 11.3%
286,559 $2.58 Million
Q2 2020

Aug 13, 2020

BUY
$8.12 - $13.12 $37,563 - $60,693
4,626 Added 1.45%
323,078 $3.98 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $92,596 - $186,161
13,841 Added 4.54%
318,452 $2.86 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $961,013 - $1.58 Million
147,169 Added 93.48%
304,611 $2.99 Million
Q3 2019

Nov 13, 2019

SELL
$6.16 - $9.6 $64,840 - $101,049
-10,526 Reduced 6.27%
157,442 $1.08 Million
Q2 2019

Aug 09, 2019

SELL
$8.12 - $15.72 $241,383 - $467,308
-29,727 Reduced 15.04%
167,968 $1.55 Million
Q1 2019

May 08, 2019

BUY
$15.58 - $20.01 $185,433 - $238,159
11,902 Added 6.41%
197,695 $3.1 Million
Q4 2018

Feb 07, 2019

SELL
$14.59 - $23.84 $146,994 - $240,188
-10,075 Reduced 5.14%
185,793 $2.87 Million
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $110,586 - $134,688
5,251 Added 2.75%
195,868 $4.22 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $357,167 - $526,273
21,298 Added 12.58%
190,617 $4.64 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $252,768 - $334,448
15,154 Added 9.83%
169,319 $2.89 Million
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $1.04 Million - $1.76 Million
-92,392 Reduced 37.47%
154,165 $2.92 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $380,149 - $793,601
24,669 Added 11.12%
246,557 $4.34 Million
Q2 2017

Aug 14, 2017

BUY
N/A
221,888
221,888 $7.37 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.